The popularity of Viagra initially sparked a period of growth for pharma, but recent changes present a uncertain scenario for shareholders. Off-patent alternatives are eating into profits, and persistent legal battles https://sahiloyls200592.glifeblog.com/39824183/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-bet